Celldex Therapeutics
CLDX
CLDX
140 hedge funds and large institutions have $293M invested in Celldex Therapeutics in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 47 increasing their positions, 42 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $281M → $293M (+$11.2M)
2% more call options, than puts
Call options by funds: $1.88M | Put options by funds: $1.85M
Holders
140
Holding in Top 10
1
Calls
$1.88M
Puts
$1.85M
Top Buyers
| 1 | +$19.7M | |
| 2 | +$11.6M | |
| 3 | +$2.24M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.96M |
| 5 |
QI
QS Investors
New York
|
+$1.47M |
Top Sellers
| 1 | -$4.02M | |
| 2 | -$3.55M | |
| 3 | -$3.29M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.99M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.76M |